Torrey Pines Law Group assists clients with traditional due diligence in mergers, acquisitions, investments, public offerings, licenses, and other business transactions. This includes review of corporate structure and business formation documents, tax standing, intellectual property, material assets, contracts, employees and management, litigation, regulatory compliance, and a number of other considerations.
What distinguishes our firm, however, is our international expertise with complex in- and out-licensing, conveying, assigning, and transferring a variety of legal rights related to life sciences and healthcare innovations. For example, some of these rights can be securitized and freely transferred, but others are personal to the inventors of the technology. Other rights related to the supply of a life sciences or healthcare innovation may be obtained in research, Open-Source, supply, CMC, and sublicense agreements, and other rights may be conveyed under distrubition, co-marketing, and collaboration agreements, or in mergers and acquisitions.
Overall, life sciences and healthcare technologies, including artificial intelligence, biotechnology, specialty chemical, pharmaceutical, and medical device technologies, are highly regulated and complex to understand or review from a scientific, business, and legal standpoint.
Our firm has unique resources which enables us to research and analyze background information, establish a listing of risks and gaps, and estimate the value and potential downside risks of business transactions. Our legal opinions practice can provide formal written letters to memorialize our conclusions, which is associated with a number of valuable benefits.
For information on these and other legal, regulatory, and business matters, please contact us.
Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.
We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.